Syringaresinol-4-O-β-d-glucoside alters lipid and glucose metabolism in HepG2 cells and C2C12 myotubes.
about
Syringaresinol-4-O-β-d-glucoside alters lipid and glucose metabolism in HepG2 cells and C2C12 myotubes.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Syringaresinol-4-O-β-d-glucosi ...... epG2 cells and C2C12 myotubes.
@en
type
label
Syringaresinol-4-O-β-d-glucosi ...... epG2 cells and C2C12 myotubes.
@en
prefLabel
Syringaresinol-4-O-β-d-glucosi ...... epG2 cells and C2C12 myotubes.
@en
P2093
P2860
P1476
Syringaresinol-4-O-β-d-glucosi ...... epG2 cells and C2C12 myotubes.
@en
P2093
Jianhe Wei
Quanyang Zhang
Shuai Wang
Xiaopo Zhang
P2860
P304
P356
10.1016/J.APSB.2017.04.008
P577
2017-05-09T00:00:00Z